Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Ribbon-shaped microgels as bioinks for 3D bioprinting of anisotropic tissue structures

Lee HP., Tai M., Jones SJ., Tong X., Kim S., Jansman MMT.

Laboratory Study on Face & Skin, published in Bioact Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Bioact Mater (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41551773
PMCID
PMC12810552
DOI
10.1016/j.bioactmat.2025.12.040

Abstract (original English)

Granular microgels are attractive bioinks for bioprinting due to their injectability, printability, modularity, and enhanced macroporosity compared to conventional nanoporous hydrogels. Despite the potential of microgels for bioprinting, most previous work has relied on spherical microgels and produced isotropic tissues, whereas many native tissues are inherently anisotropic. While emerging studies have explored non-spherical microgels for bioprinting, there remains a need for bioinks that support cell alignment and tunable niche cues. Microribbons (μRB) are anisotropic ribbon-shaped microgels, but the potential of μRBs as bioinks for printing 3D anisotropic tissues remains unexplored. Here, we report the development of μRBs with tunable stiffness as bioinks for extrusion-based bioprinting and demonstrate that μRB bioinks maintain excellent printability and align during extrusion. μRB bioinks support alignment of MSCs and endothelial cells, with greater alignment as μRB stiffness increases. Increasing μRB stiffness also accelerates mesenchymal stromal cell osteogenesis in 3D. Finally, we demonstrate the potential of μRB bioinks for modeling breast cancer-bone metastasis, which features spatial patterning of multiple cell types to model cancer cell invasion at the tissue interface. Together, these results establish ribbon-shaped microgels as a new class of anisotropic bioinks, o

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research